TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
DEAD

Serial Number

87178937

Owner

GENENTECH, INC.

Attorney

Robin Weatherhead

First Use Date

May 18, 2016

Filing Date

Sep 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG Trademark

Serial Number: 87178937

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG is a trademark filed by GENENTECH, INC. on September 21, 2016. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

GENENTECH, INC. (827 trademarks)

SOUTH SAN FRANCISCO, CA 940804990

Entity Type: 03

Trademark Details

Filing Date

September 21, 2016

Registration Date

Not Registered

First Use Anywhere

May 18, 2016

First Use in Commerce

May 18, 2016

Published for Opposition

April 3, 2018

Goods & Services

Providing online information services, namely, prescription drug information in relation to the treatment and symptoms of disorders relating to oncology, autoimmune, or inflammatory diseases

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 23, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2021 REAP
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 27, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 27, 2020 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
May 15, 2020 GNFN
FINAL REFUSAL E-MAILED
May 15, 2020 GNFR
SU - FINAL REFUSAL - WRITTEN
May 15, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 18, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Nov 16, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 16, 2019 AITU
USE AMENDMENT FILED
Nov 6, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 6, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2019 EXRA
SOU EXTENSION 2 GRANTED
May 6, 2019 EX2G
SOU EXTENSION 2 FILED
May 6, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
May 6, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2018 EXRA
SOU EXTENSION 1 GRANTED
Nov 5, 2018 EX1G
SOU EXTENSION 1 FILED
Nov 5, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 29, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 3, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 14, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2018 CRFA
ASSIGNED TO LIE
Feb 12, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 3, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 3, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 3, 2017 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 2, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 25, 2017 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 23, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 23, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 23, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 23, 2017 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 28, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2016 NWOS
NEW APPLICATION ENTERED
Sep 24, 2016 NWAP